Optoacoustic Imaging Systems Company W/Patents 1366

The Company is pioneering advanced imaging technologies that integrate laser light and ultrasound to enable high-resolution, molecular-contrast visualization of the human body. Its proprietary systems are designed for a range of clinical applications, including cancer and vascular disease diagnostics, image-guided surgery, and minimally invasive therapeutic interventions. Backed by significant funding and a strong patent portfolio, the company has successfully commercialized research-focused imaging solutions and is advancing toward regulatory approval for its first clinical system. With a robust pipeline of innovative products targeting critical healthcare challenges, it is well-positioned to make a significant impact in the global medical imaging market. Confidentiality is a concern for the Seller as he seeks just the right buyer, and so the location information provided in the ad is that of the broker, and not of the Business. Business location and name will be shared once a qualified Buyer prospect is vetted. NDA is required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Detailed Information Facilities: Leased office space Competition: The Company operates in a competitive medical imaging landscape, where its advanced optoacoustic and ultrasound technology offers superior 3D full-view imaging, greater depth, higher image contrast, and significantly better quantitative accuracy compared to its competitors. With a competitive price point and high imaging rate, it stands out against firms that primarily focus on 2D imaging, have lower resolution, or provide limited imaging depth and contrast. Growth & Expansion: The Company is innovating optoacoustic tomography with ultrasound, targeting a $14.0bn clinical systems market with validated technology and a $19.0mm sales pipeline. Backed by patents and industry experts, it is raising funds to advance commercialization and achieve regulatory milestones. Financing: If the price and deal structure is right. Support & Training: Owner and Management team to stay on. Reason for Selling: Grow with the right buyer.The Company is pioneering advanced imaging technologies that integrate laser light and ultrasound to enable high-resolution, molecular-contrast visualization of the human body. Its proprietary systems are designed for a range of clinical applications, including cancer and vascular disease diagnostics, image-guided surgery, and minimally invasive therapeutic interventions. Backed by significant funding and a strong patent portfolio, the company has successfully commercialized research-focused imaging solutions and is advancing toward regulatory approval for its first clinical system. With a robust pipeline of innovative products targeting critical healthcare challenges, it is well-positioned to make a significant impact in the global medical imaging market. Confidentiality is a concern for the Seller as he seeks just the right buyer, and so the location information provided in the ad is that of the broker, and not of the Business. Business location and name will be shared once a qualified Buyer prospect is vetted. NDA is required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Detailed Information Facilities: Leased office space Competition: The Company operates in a competitive medical imaging landscape, where its advanced optoacoustic and ultrasound technology offers superior 3D full-view imaging, greater depth, higher image contrast, and significantly better quantitative accuracy compared to its competitors. With a competitive price point and high imaging rate, it stands out against firms that primarily focus on 2D imaging, have lower resolution, or provide limited imaging depth and contrast. Growth & Expansion: The Company is innovating optoacoustic tomography with ultrasound, targeting a $14.0bn clinical systems market with validated technology and a $19.0mm sales pipeline. Backed by patents and industry experts, it is raising funds to advance commercialization and achieve regulatory milestones. Financing: If the price and deal structure is right. Support & Training: Owner and Management team to stay on. Reason for Selling: Grow with the right buyer.